Follow
David G Strauss
Title
Cited by
Cited by
Year
Defining left bundle branch block in the era of cardiac resynchronization therapy
DG Strauss, RH Selvester, GS Wagner
The American journal of cardiology 107 (6), 927-934, 2011
6162011
The comprehensive in vitro proarrhythmia assay (CiPA) initiative—update on progress
T Colatsky, B Fermini, G Gintant, JB Pierson, P Sager, Y Sekino, ...
Journal of pharmacological and toxicological methods 81, 15-20, 2016
3202016
A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm
B Fermini, JC Hancox, N Abi-Gerges, M Bridgland-Taylor, KW Chaudhary, ...
Journal of biomolecular screening 21 (1), 1-11, 2016
2552016
Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: a randomized clinical trial
MK Matta, R Zusterzeel, NR Pilli, V Patel, DA Volpe, J Florian, L Oh, ...
Jama 321 (21), 2082-2091, 2019
2272019
An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
WJ Crumb Jr, J Vicente, L Johannesen, DG Strauss
Journal of pharmacological and toxicological methods 81, 251-262, 2016
2142016
International multisite study of human-induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment
K Blinova, Q Dang, D Millard, G Smith, J Pierson, L Guo, M Brock, HR Lu, ...
Cell reports 24 (13), 3582-3592, 2018
2112018
Differentiating drug‐induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil
L Johannesen, J Vicente, JW Mason, C Sanabria, K Waite‐Labott, ...
Clinical Pharmacology & Therapeutics 96 (5), 549-558, 2014
2082014
Comprehensive translational assessment of human-induced pluripotent stem cell derived cardiomyocytes for evaluating drug-induced arrhythmias
K Blinova, J Stohlman, J Vicente, D Chan, L Johannesen, ...
Toxicological Sciences 155 (1), 234-247, 2017
1832017
Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data
R Zusterzeel, KA Selzman, WE Sanders, DA Caņos, KM O’Callaghan, ...
JAMA internal medicine 174 (8), 1340-1348, 2014
1832014
The QRS complex-a biomarker that" images" the heart: QRS scores to quantify myocardial scar in the presence of normal and abnormal ventricular conduction
DG Strauss, RH Selvester
Journal of electrocardiology 42 (1), 85, 2009
1672009
Effectiveness of prehospital wireless transmission of electrocardiograms to a cardiologist via hand-held device for patients with acute myocardial infarction (from the Timely …
GL Adams, PT Campbell, JM Adams, DG Strauss, K Wall, J Patterson, ...
The American journal of cardiology 98 (9), 1160-1164, 2006
1532006
ECG Quantification of Myocardial Scar in Cardiomyopathy Patients With or Without Conduction Defects
DG Strauss, RH Selvester, JAC Lima, H Arheden, JM Miller, ...
Circulation: Arrhythmia and Electrophysiology 1 (5), 327-336, 2008
1512008
Effect of sunscreen application on plasma concentration of sunscreen active ingredients: a randomized clinical trial
MK Matta, J Florian, R Zusterzeel, NR Pilli, V Patel, DA Volpe, Y Yang, ...
Jama 323 (3), 256-267, 2020
1392020
Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment
S Dutta, KC Chang, KA Beattie, J Sheng, PN Tran, WW Wu, M Wu, ...
Frontiers in Physiology 8, 616, 2017
1312017
Improving the in silico assessment of proarrhythmia risk by combining hERG (human ether-ā-go-go-related gene) channel–drug binding kinetics and multichannel pharmacology
Z Li, S Dutta, J Sheng, PN Tran, W Wu, K Chang, T Mdluli, DG Strauss, ...
Circulation: Arrhythmia and Electrophysiology 10 (2), e004628, 2017
1272017
Comprehensive T wave morphology assessment in a randomized clinical study of dofetilide, quinidine, ranolazine, and verapamil
J Vicente, L Johannesen, JW Mason, WJ Crumb, E Pueyo, N Stockbridge, ...
Journal of the American Heart Association 4 (4), e001615, 2015
1222015
Late sodium current block for drug‐induced long QT syndrome: results from a prospective clinical trial
L Johannesen, J Vicente, JW Mason, C Erato, C Sanabria, K Waite‐Labott, ...
Clinical Pharmacology & Therapeutics 99 (2), 214-223, 2016
1162016
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
Z Li, BJ Ridder, X Han, WW Wu, J Sheng, PN Tran, M Wu, A Randolph, ...
Clinical Pharmacology & Therapeutics 105 (2), 466-475, 2019
1012019
Mechanistic model‐informed proarrhythmic risk assessment of drugs: review of the “CiPA” initiative and design of a prospective clinical validation study
J Vicente, R Zusterzeel, L Johannesen, J Mason, P Sager, V Patel, ...
Clinical Pharmacology & Therapeutics 103 (1), 54-66, 2018
962018
16. Myocardial Infarction
RH Selvester, DG Strauss, GS Wagner
94*2010
The system can't perform the operation now. Try again later.
Articles 1–20